Zhongnan Medical Journal Press

Home Results

A total of 1407 result was found. Results that relate to 2

Construction and validation of a prognostic prediction model for osteosarcoma in children based on the SEER database

Published on New Medicine 2025,35(7):800-809.
559 times 149 times

ZHANG Lei LI Yuwan WU Yindan XU Zhi SHAO Jinfu

Children Osteosarcoma Prognosis Predictive model Nomogram SEER database
Details
Trends in the burden of spinal cord injury in China from 1990 to 2021

Published on New Medicine 2025,35(7):810-818.
636 times 144 times

CAI Yan CHEN Yuan ZHANG Wenxi

Disease burden Spinal cord injury Age-standardized incidence rate Age-standardized prevalence rate Age-period-cohort effect Trend analysis
Details
WTAP promotes lipopolysaccharides-induced ferroptosis in human renal tubular epithelial cells by regulating ACSL4 m6A methylation

Published on New Medicine 2025,35(7):827-835.
641 times 155 times

ZHANG Qin TANG Qing CHEN Bingyang

Wilms' tumor 1-associating protein Long chain acyl-CoA synthetase 4 N6-methyladenosine Ferroptosis Sepsis
Details
The role of zinc homeostasis in prostate diseases and potential mechanisms

Published on New Medicine 2025,35(7):846-854.
571 times 151 times

HAN Yutong FAN Jiuming WANG Tiankun QI Zihao ZHANG Yuanyuan HOU Junqing

Zinc Zinc Homeostasis Prostatic diseases Prostate cancer Benign prostatic hyperplasia
Details
Guide on Methodological Standards in Pharmacoepidemiology in China (2nd edition) and their series interpretation (7): selection of control groups

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):725-733.
920 times 204 times

TIAN Qinxi ZHAN Siyan SUN Feng YANG Zhirong

Pharmacoepidemiology Methodology Guidelines Control Interventional research Non-interventional research
Details
Evaluation of the efficacy and safety of dapagliflozin and empagliflozin in the treatment of patients with diabetic nephropathy based on real-world data

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):734-742.
996 times 156 times

HU Ruiwen JI Cheng LI Li

Diabetic nephropathy Dapagliflozin Empagliflozin Real world study Efficacy Safety
Details
Development and application of a rapid identification algorithm for cutaneous lupus erythematosus and its subtypes based on medical insurance databases

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):743-752.
801 times 108 times

WANG Yutong MENG Xianglong PAN Yu WEI Chen JIN Hui WANG Shengfeng

Cutaneous lupus erythematosus Medical insurance Rapid identification algorithm
Details
Safety of budesonide inhalation aerosol for chronic obstructive pulmonary disease: a Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):771-784.
782 times 120 times

QIN Honghua GUO Haiyan LI Haifeng TONG Xiaona WANG Ying

Budesonide Chronic obstructive pulmonary disease Adverse drug reaction Meta-analysis Randomized controlled trial
Details
Efficacy and safety of tislelizumab combined with anlotinib in the treatment of advanced non-small cell lung cancer: a Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):785-794.
951 times 124 times

TENG Xinli LIU Bin XIU Junli ZHOU Xiaohong

Tislelizumab Anlotinib Non-small cell lung cancer Meta-analysis Systematic review
Details
Efficacy and safety of dose-optimization strategies for CDK4/6 inhibitors in HR+/HER2- advanced breast cancer: a Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):795-805.
750 times 102 times

ZHENG Yating LIU Songling ZHOU Liyan

CDK4/6 inhibitor HR+/HER2- breast cancer Dose-optimization Meta-analysis
Details
Sugemalimab as first-line treatment for non-small cell lung cancer: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):806-814.
818 times 101 times

HOU Yibing KANG Shuo GONG Yuan WANG Xiaohui NIE Ying LIU Huanlong

Sugemalimab Non-small cell lung cancer Effectiveness Safety Economics Rapid health technology assessment
Details
A case report of acute kidney injury caused by semaglutide in combination with multiple medications

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):835-840.
837 times 123 times

GU Jiamei TANG Chenquan JIANG Yi YIN Hao FENG Chen XUE Yi

Semaglutide Metformin Dapagliflozin Sacubitril/Valsartan Acute kidney injury Adverse reactions
Details
An epidemiological study of overweight and obesity among primary and secondary school students in Baoshan District, Shanghai

Published on Journal of Mathematical Medicine 2025,38(7):491-499.
883 times 136 times

MAI Yiyi XIANG Man HUANG Aiyi ZHU Xinya LI Meiyue LI Guangping JI Wei RONG Fen

Primary and secondary school students Overweight Obesity Prevalence
Details
Analysis of secular variation trends of incidence and SARIMA model prediction of other infectious diarrhea in Dali Prefecture from 2005 to 2024

Published on Journal of Mathematical Medicine 2025,38(7):500-507.
774 times 106 times

XU Ran MA Yajiao YOU Fengfeng CHEN Ling MA Yi ZHAO Runfang ZHAO Jing Lyu Shisai HE Zuo

Other infectious diarrheal Incidence Trend Joinpoint regression SARIMA model
Details
Analysis of the spectrum-effect relationship and key influencing factors of water-soluble components of Salvia miltiorrhiza based on stepwise regression model

Published on Journal of Mathematical Medicine 2025,38(7):508-517.
791 times 96 times

XUE Weihang CHEN Yang ZHOU Qinyu HONG Yujiao ZHAO Yongyi LIU Hui

Salvia miltiorrhiza Water-soluble components Spectrum-effect analysis Influencing factors Stepwise regression Cardiovascular protection
Details